In this special HITea Heard in the Halls at HLTH episode, Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions, sits down with Grace Vinton to explore the critical role of diagnostic intelligence—from GLP-1s and cardiometabolic health to the future of cancer care.
Dr. Schulz discusses how health plans can harness lab insights to pinpoint the right patients, promote health equity, and support the appropriate use of high-cost therapies. She emphasizes that diagnostic intelligence helps ensure limited treatments, such as GLP-1s, reach those most likely to benefit—driving better outcomes across entire populations.
